Results 81 to 90 of about 16,727 (107)
Some of the next articles are maybe not open access.
ACS Infectious Diseases
Endochin-like quinolones (ELQs) define a class of small molecule antimicrobials that target the mitochondrial electron transport chain of various human parasites by inhibiting their cytochrome bc1 complexes.
Pratap Vydyam +2 more
exaly +2 more sources
Endochin-like quinolones (ELQs) define a class of small molecule antimicrobials that target the mitochondrial electron transport chain of various human parasites by inhibiting their cytochrome bc1 complexes.
Pratap Vydyam +2 more
exaly +2 more sources
Neuronal mitochondrial dysfunction and oxidative stress are key pathophysiologic mechanisms of diabetic peripheral neuropathy (DPN). KU‐596 is a small molecule modulator of heat shock protein 90 (Hsp90) that can reverse clinically relevant measures of ...
Brian S J Blagg, Rick T Dobrowsky
exaly +2 more sources
World Neurosurgery, 2019
OBJECTIVE Cranioplasty is a technically simple procedure intended to repair defects of the skull to provide protection after craniectomy, improve functional outcomes, and restore cosmesis.
Mun-Chun Yeap +11 more
semanticscholar +1 more source
OBJECTIVE Cranioplasty is a technically simple procedure intended to repair defects of the skull to provide protection after craniectomy, improve functional outcomes, and restore cosmesis.
Mun-Chun Yeap +11 more
semanticscholar +1 more source
RHPN1-AS1 drives the progression of hepatocellular carcinoma via regulating miR-596/IGF2BP2 axis.
Current pharmaceutical design, 2019BACKGROUND Hepatocellular carcinoma (HCC) is one of the most deadly cancer worldwide, and its incidence is especially in China. Multiple long non-coding RNAs (lncRNAs) have been recently identified as crucial oncogenic factors or tumor suppressors.
Hu Fen +6 more
semanticscholar +1 more source
Potential of tumor-suppressive miR-596 targeting LGALS3BP as a therapeutic agent in oral cancer
Atiphan Pimkhaokham +2 more
exaly +2 more sources
Journal of Clinical Oncology, 2019
TPS2071 Background: GBM is the most aggressive primary brain tumor in adults and is extremely difficult to treat. Patients with GBM tend to progress rapidly within weeks or months. Median overall survival is only 12–15 months despite aggressive treatment,
M. Rosenthal +10 more
semanticscholar +1 more source
TPS2071 Background: GBM is the most aggressive primary brain tumor in adults and is extremely difficult to treat. Patients with GBM tend to progress rapidly within weeks or months. Median overall survival is only 12–15 months despite aggressive treatment,
M. Rosenthal +10 more
semanticscholar +1 more source

